Prof. Zhouguang Hui 惠周光
Chief Physician, Professor
Department of Radiation Oncology, Cancer Hospital, Chinese Academy of Medical Sciences (National Cancer Center), Beijing
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Radiation therapy for lung cancer, esophageal cancer, thymoma, and other thoracic tumors. Management of complex cases and application of new radiation therapy techniques.
Dr. Hui is a Chief Physician, Professor, and Doctoral Supervisor at Peking Union Medical College. Dr. Hui holds a 2003 oncology doctorate from Peking Union Medical College Hospital and completed postdoctoral work at Louisiana State University Health Sciences Center and Baylor College of Medicine, with visiting scholar experience at MD Anderson Cancer Center. Clinical and research focus includes thoracic tumor radiation therapy and tumor big data applications.
Professional roles
- Vice Chair, Youth Committee of the Radiation Oncology Branch, Chinese Medical Association
- Vice Chair, Youth Committee on Tumor Radiotherapy, China Anti-Cancer Association
- Vice Chair, Professional Society of Geriatric Tumor Radiotherapy
- Standing Committee Member, Expert Committee on Tumor Radiotherapy, Chinese Society of Clinical Oncology (CSCO)
Name order: in Chinese the family name comes first (Hui Zhouguang). Papers usually list the name as Zhouguang Hui or Hui Z.
Selected publications
137 papers on PubMed matched by name and affiliation; 60 as first or senior author since 2016. Most recent first- or senior-author papers:
- Br J Surg, 2026 (senior author): Beyond SANO: the future of active surveillance for oesophageal cancer. PubMed 42237819
- Int J Cancer, 2026 (senior author): Optimal Neoadjuvant Approach for Resectable Esophageal Cancer in the Era of Immunotherapy. PubMed 42163537
- Biomedicines, 2026 (senior author): MIF-Associated Immunosuppressive CAF Remodeling Predicts Poor Prognosis During Lung Adenocarcinoma Progression: A Single-Cell and Multicohort Transcriptomic Study. PubMed 42512054
- Nurs Rep, 2026 (senior author): Hotspots and Trends in Nursing Interventions for Breast Cancer Patients Undergoing Radiotherapy: A Bibliometric Analysis. PubMed 42505997
- Radiother Oncol, 2025 (senior author): A multidimensional deep ensemble learning model predicts pathological response and outcomes in esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy from pretreatment CT imaging: A multicenter study. PubMed 40939680
- Int J Radiat Oncol Biol Phys, 2025 (senior author): Neoadjuvant Immunochemoradiation Therapy Versus Chemoradiation Therapy in Esophageal Cancer: A Systematic Review and Meta-Analysis of Reconstructed Individual Patient Data. PubMed 40319926
- Nurs Rep, 2025 (senior author): Artificial Intelligence in Nursing Decision-Making: A Bibliometric Analysis of Trends and Impacts. PubMed 40559489
- Radiat Oncol, 2025 (senior author): Postoperative radiotherapy improves disease-free survival of EGFR wild-type pN2 non-squamous-cell non-small-cell lung cancer (Nsq-NSCLC) patients after complete resection: a propensity score matching analysis. PubMed 40082994
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion